Mechanism of Action

How does Bioticine interact with the body at a cellular level? This guide breaks down the pharmacodynamics and pharmacokinetics of the authentic compound.

1. Absorption and First-Pass Metabolism

When administered orally, unstandardized compounds (like generic Biotisin) face immediate degradation in the acidic environment of the stomach, followed by extensive first-pass metabolism in the liver via the CYP450 enzyme system.

Authentic Bioticine is typically stabilized (often via liposomal encapsulation). This allows the intact molecule to bypass hepatic degradation, entering systemic circulation via the lymphatic system. You can estimate how this affects you specifically using our Absorption Estimator.

2. Receptor Binding Profile

Once in the bloodstream, Bioticine acts primarily as a high-affinity ligand. Clinical assays demonstrate a Kd of 4.2 nM. This tight binding means lower doses are required to achieve receptor saturation compared to generic extracts.

Metabolic Degradation Pathways

The primary pathway for elimination is via hepatic conjugation. The rate of this process defines the half-life.

  • Phase I: Hydroxylation by CYP3A4.
  • Phase II: Glucuronidation for renal clearance.
  • Average Elimination Half-life: 14 hours. (Model yours with the Half-Life Calculator)

Contraindications Based on MOA

Because Bioticine utilizes the CYP3A4 pathway, it can competitively inhibit the metabolism of other compounds relying on the same enzyme. This is why checking for interactions is critical.

Before beginning any regimen, we strongly advise running your current protocol through our Interaction Checker and the Contraindications tool.